Clinical reviews in allergy & immunology · 2026
The Dual Roles of Innate Lymphoid Cells in Antibacterial Defense and Bacterial Immune Evasion.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hu Yuting, Liu Huaqing, Liu Qi, Sun Pengfei, Chen Changjiang, Sha Zhou, Wang Zhizeng, Wu Haibo
Аннотация
Innate lymphoid cells (ILCs) are critical regulators of early immune responses at mucosal barriers. As sentinels of the innate immune system, they rapidly detect infection-induced signals and initiate tissue-protective programs prior to the full activation of adaptive immunity. Emerging evidence shows that bacteria activate ILCs through multiple mechanisms, including direct recognition via pattern recognition receptors (PRRs), cytokine-mediated interactions with myeloid and epithelial cells, and metabolic and transcriptional modulation. Once activated, distinct ILC subsets coordinate antibacterial defense through cytotoxic activity and cytokine-driven regulation of macrophages, neutrophils, and epithelial cells. Notably, these pathways can be subverted by both pathogenic and commensal bacteria to manipulate ILC responses, enabling immune evasion and persistence, yet how bacterial signals are integrated and dynamically regulated by ILCs across tissues and disease contexts remains incompletely understood. Here, we synthesize recent progress in elucidating the molecular and cellular mechanisms underlying bacteria-ILC crosstalk, highlight emerging concepts and unresolved questions, and discuss how context-dependent ILC responses contribute to either host protection or disease progression. By integrating findings across infection models and mucosal environments, we propose a unifying framework for ILC-mediated antibacterial immunity and its dysregulation and highlight the therapeutic potential of targeting ILC-associated pathways as promising strategies for chronic and persistent bacterial infections.